Tag: JPM

Quiet Week in M&A: Why a Slow Period Was a Good Thing

January 19, 2026

Quiet Week in M&A: Why a Slow Period Was a Good Thing

JPM Conference 2026 Takeaways: STATus Report Video

January 16, 2026

JPM Conference 2026 Takeaways: STATus Report Video

Day 2 Conference: Gilead News & FDA Response

January 13, 2026

Day 2 Conference: Gilead News & FDA Response

Investor Noubar Afeyan Warns of Science Backlash in U.S

January 12, 2026

Investor Noubar Afeyan Warns of Science Backlash in U.S

JPM 2026 Biotech: Adam Feuerstein’s Key Advice

January 12, 2026

JPM 2026 Biotech: Adam Feuerstein’s Key Advice

Alnylam’s Five-Year Plan Amidst Drug Sales Shortfall

January 12, 2026

Alnylam’s Five-Year Plan Amidst Drug Sales Shortfall

FDA Delays Expedited Filing for Dravet’s Drug in Stoke Case

January 11, 2026

FDA Delays Expedited Filing for Dravet’s Drug in Stoke Case

JPM 2026: More Deals, Happy CEOs

January 8, 2026

JPM 2026: More Deals, Happy CEOs

Banks Watching for Economic Trouble: Credit Quality Signals

October 18, 2025

Banks Watching for Economic Trouble: Credit Quality Signals

Web Analytics Made Easy - Statcounter